Berkshire Asset Management’s Sanofi SNY Stock Holding History

Berkshire Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,250	Closed	-$211K	–	237
2023 Q4	$211K	Buy	+4,250	New	+$208K	0.01%	223
2016 Q4	–	Sell	-8,260	Closed	-$315K	–	187
2016 Q3	$315K	Hold	8,260	–	–	0.05%	143
2016 Q2	$346K	Hold	8,260	–	–	0.05%	138
2016 Q1	$332K	Hold	8,260	–	–	0.05%	128
2015 Q4	$352K	Hold	8,260	–	–	0.06%	119
2015 Q3	$392K	Hold	8,260	–	–	0.07%	106
2015 Q2	$409K	Sell	8,260 -107	-1%	-$5.42K	0.07%	115
2015 Q1	$414K	Buy	8,367 +1,167	+16%	+$55.8K	0.07%	114
2014 Q4	$328K	Sell	7,200 -4,050	-36%	-$197K	0.06%	130
2014 Q3	$635K	Hold	11,250	–	–	0.12%	100
2014 Q2	$598K	Hold	11,250	–	–	0.11%	99
2014 Q1	$588K	Buy	11,250 +300	+3%	+$15.2K	0.11%	95
2013 Q4	$587K	Buy	10,950 +6,900	+170%	+$356K	0.11%	104
2013 Q3	$205K	Sell	4,050 -284	-7%	-$14.4K	0.05%	132
2013 Q2	$223K	Buy	+4,334	New	+$231K	0.06%	111

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Berkshire Asset Management's SNY Position: Q1 2024 in Review

Berkshire Asset Management sold out of Sanofi (SNY) in Q1 2024, closing a stake of 4,250 shares — an estimated $211K sold.

Berkshire Asset Management first reported a position in SNY in Q2 2013 and held it in 15 quarters. The position peaked at $635K in Q3 2014. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Berkshire Asset Management reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
Berkshire Asset Management sold 4,250 Sanofi shares in Q1 2024, an estimated $211K.
Berkshire Asset Management first reported a position in Sanofi in Q2 2013 and held it in 15 quarters.
Berkshire Asset Management's Sanofi position peaked at $635K in Q3 2014.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Berkshire Asset Management's 13F filing for Q1 2024, filed 14 May 2024.